Pacira Biosciences
PCRX
#6179
Rank
C$1.30 B
Marketcap
C$33.21
Share price
-4.12%
Change (1 day)
-9.17%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: C$1.30 Billion

As of May 2026 Pacira Biosciences has a market cap of C$1.30 Billion. This makes Pacira Biosciences the world's 6179th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026C$1.30 B-19.95%
2025C$1.63 B25.29%
2024C$1.30 B-37.35%
2023C$2.07 B-13.55%
2022C$2.40 B-29.63%
2021C$3.41 B3.05%
2020C$3.31 B33.69%
2019C$2.47 B2.64%
2018C$2.41 B3.75%
2017C$2.32 B43.42%
2016C$1.62 B-58.64%
2015C$3.92 B5.53%
2014C$3.71 B80.69%
2013C$2.05 B263.22%
2012C$0.56 B273.85%
2011C$0.15 B

End of Day market cap according to different sources

On May 2nd, 2026 the market cap of Pacira Biosciences was reported to be:

C$1.34 Billion
by Nasdaq info icon info icon
C$1.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
C$2.03 B 56.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
C$0.16 B-87.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C$1.47 B 12.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
C$0.62 B-52.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
C$0.32 B-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
C$11.02 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA